Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Total Debt / Equity

Arbutus Biopharma Cp Total Debt / Equity Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Total Debt / Equity from 2016 to 2017. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Arbutus Biopharma Cp Total Debt / Equity for the quarter ending December 12, 2017 was $7m a 3.48% increase of 0m year over year
  • Arbutus Biopharma Cp Total Debt / Equity for the last 12 months ending December 12, 2017 was $7m a 3.48% increase of 0m year over year
  • Arbutus Biopharma Cp Annual Total Debt / Equity for 2017 was $7m a 10.09% increase of 1m from 2016
  • Arbutus Biopharma Cp Annual Total Debt / Equity for 2016 was $6m
Other Ratios Metrics:
  • Arbutus Biopharma Cp Total Debt / Capital for the quarter ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
View Chart On Koyfin

Quarterly ABUS Total Debt / Equity Data

12/2017$7m
09/2017$7m
06/2017$7m
03/2017$6m
12/2016$6m

Annual ABUS Total Debt / Equity Data

2017$7m
2016$6m